Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non-Current Debt: 2022-2025

Historic Non-Current Debt for Orchestra BioMed Holdings (OBIO) over the last 1 years, with Sep 2025 value amounting to $14.2 million.

  • Orchestra BioMed Holdings' Non-Current Debt was N/A to $14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year change of. This contributed to the annual value of $14.3 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Orchestra BioMed Holdings' Non-Current Debt stood at $14.2 million, which was down 1.25% from $14.4 million recorded in Q2 2025.
  • Orchestra BioMed Holdings' 5-year Non-Current Debt high stood at $14.4 million for Q2 2025, and its period low was $9.5 million during Q4 2022.
  • For the 3-year period, Orchestra BioMed Holdings' Non-Current Debt averaged around $12.7 million, with its median value being $14.2 million (2024).